Application of CD204 (scavenger receptor) to histopathological diagnosis and production of new anti-macrophage antibodies

CD204(清道夫受体)在组织病理学诊断和新型抗巨噬细胞抗体生产中的应用

基本信息

  • 批准号:
    16390108
  • 负责人:
  • 金额:
    $ 8.77万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    2004
  • 资助国家:
    日本
  • 起止时间:
    2004 至 2007
  • 项目状态:
    已结题

项目摘要

Scavenger receptors possess wide-ranged ligand-binding specificities and are considered to be one of the pattern recognition receptors that play important roles in host defence. Among such receptors, CD204 (Class A scavenger receptor Type I and II) and CD163 (hemoglobin scavenger receptor) are expressed exclusively on macrophages and considered to be a good marker for macrophages in histopathology. Using self-made antibodies, we have shown that CD204 and CD163 are positive for resident macrophages and a population of inflammatory macrophages in paraffin sections. In granulomatous diseases such as tuberculosis and sarcoidosis, infiltrated macropages surrounding the granulomas were positive for CD204 and CD163, however multinucleated giant cells were negative or only weakly labeled. Since CD204 and CD163 are induced in alternatively activated macrophages, these antibodies are considered to be valuable tools to label such macrophage subpopulation in hitopathological specimens.In animal models of acute myocardial infarction and high-dose oxygen-induced lung injury, CD204-deficient mice showed exacerbation of disease process in both models. In myocardial infarction model, CD204-deficiency showed increased ratio of cardiac rupture with increased expression of TNF- a and enhanced activation of matrix metalloproteinases (MMP). In lung injury model, CD204-deficiency also showed higher expression of TNF- a and increased MMP activity. These results indicate that CD204-positive macrophages regulate inflammatory process by suppressing the excessive inflammatory responses.In the future experiments, such anti-inflammatory alternatively activated macrophages will be evaluated in various human diseases using self-made antibodies against CD204 and CD 163.
清道夫受体具有广泛的配体结合特异性,被认为是在宿主防御中发挥重要作用的模式识别受体之一。在这些受体中,CD204(A类清道夫受体I和II型)和CD163(血红蛋白清道夫受体)仅在巨噬细胞上表达,被认为是组织病理学中很好的巨噬细胞标志物。使用自制的抗体,我们发现CD204和CD163在石蜡切片中的常驻巨噬细胞和炎性巨噬细胞群中呈阳性。在结核、结节病等肉芽肿性疾病中,肉芽肿周围浸润性巨细胞CD204和CD163阳性,多核巨细胞阴性或仅弱标记。由于CD204和CD163在交替激活的巨噬细胞中被诱导,这些抗体被认为是在组织病理学标本中标记这种巨噬细胞亚群的有价值的工具。在急性心肌梗死和大剂量氧致肺损伤的动物模型中,CD204缺乏的小鼠在这两种模型中都表现出疾病过程的恶化。在心肌梗死模型中,CD204缺陷表现为心脏破裂的发生率增加,并伴随着肿瘤坏死因子-α的表达增加和基质金属蛋白酶的激活。在肺损伤模型中,CD204缺陷组也表现出较高的肿瘤坏死因子-α表达和基质金属蛋白酶活性。这些结果表明,CD204阳性的巨噬细胞通过抑制过度的炎症反应来调节炎症过程。在未来的实验中,这种抗炎或激活的巨噬细胞将利用自制的CD204和CD163抗体在各种人类疾病中进行评估。

项目成果

期刊论文数量(37)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Acyl-coenzyme A:Cholesterol acyltransferase-2 (ACAT-2) is responsible for elevated intestinal ACAT activity in diabetic rats
Class A scavenger receptor (CD204) attenuates hyperoxia-induced lung injury by reducing oxidative stress
  • DOI:
    10.1002/path.2150
  • 发表时间:
    2007-05-01
  • 期刊:
  • 影响因子:
    7.3
  • 作者:
    Kobayashi, H.;Sakashita, N.;Takeya, M.
  • 通讯作者:
    Takeya, M.
C-C chemokine receptor 2 (CCR2) deficiency improves bleomycin-induced pulmonary fibrosis by attenuation of both macrophage infiltration and production of acrophage"derived matrix metalloproteinases.
C-C趋化因子受体2(CCR2)缺陷通过减弱巨噬细胞浸润和巨噬细胞衍生的基质金属蛋白酶的产生来改善博莱霉素诱导的肺纤维化。
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Okuma T;Terasaki Y;Kaikita K;Kobayashi H;Kuziel WA;Kawasuji M;Takeya M.
  • 通讯作者:
    Takeya M.
Targeted deletion of class A macrophage scavenger receptor increases the risk of cardiac rupture after experimental myocardial infarction
  • DOI:
    10.1161/circulationaha.106.671198
  • 发表时间:
    2007-04-10
  • 期刊:
  • 影响因子:
    37.8
  • 作者:
    Tsujita, Kenichi;Kaikita, Koichi;Takeya, Motohiro
  • 通讯作者:
    Takeya, Motohiro
CD36 is not involved in scavenger receptor-mediated endocytic uptake of glycolaldehyde- and methylglyoxal-modified proteins by liver endothelial cells.
CD36 不参与清道夫受体介导的肝内皮细胞对乙醇醛和甲基乙二醛修饰蛋白的内吞摄取。
  • DOI:
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Nakajou K;・・・;Takeya M;et al.
  • 通讯作者:
    et al.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TAKEYA Motohiro其他文献

CD169+ macrophages in regional lymph nodes involved in the tumor immunity and prognosis in patients with colorectal cancer, melanoma and endometrial cancer.
区域淋巴结CD169巨噬细胞参与结直肠癌、黑色素瘤和子宫内膜癌患者的肿瘤免疫和预后。
  • DOI:
  • 发表时间:
    2015
  • 期刊:
  • 影响因子:
    0
  • 作者:
    OHNISHI Koji;KOMOHARA Yoshihiro;SAITO Yoichi;TAKEYA Motohiro
  • 通讯作者:
    TAKEYA Motohiro

TAKEYA Motohiro的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TAKEYA Motohiro', 18)}}的其他基金

Development of new therapeutic strategies for regulating macrophage activation by natural compounds
开发通过天然化合​​物调节巨噬细胞活化的新治疗策略
  • 批准号:
    23659204
  • 财政年份:
    2011
  • 资助金额:
    $ 8.77万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
ROLE OF SCAVENGER RECEPTORS IN MACROPHAGE ACTIVATION AND THEIR APPLICATION FOR DIAGNOSIS AND THERAPY
清道夫受体在巨噬细胞激活中的作用及其在诊断和治疗中的应用
  • 批准号:
    20390113
  • 财政年份:
    2008
  • 资助金额:
    $ 8.77万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
IN VIVO EXPRESSION AND PATHOLOGICAL ROLES OF SCAVENGER RECEPTOR FAMILY MOLECULES
清道夫受体家族分子的体内表达和病理作用
  • 批准号:
    13470052
  • 财政年份:
    2001
  • 资助金额:
    $ 8.77万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Role of scavenger receptors in atherogenesis and development of new therapeutic methods
清道夫受体在动脉粥样硬化形成中的作用和新治疗方法的开发
  • 批准号:
    12557023
  • 财政年份:
    2000
  • 资助金额:
    $ 8.77万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Macrophage scavenger receptor as a new macrophage marker
巨噬细胞清道夫受体作为新的巨噬细胞标记物
  • 批准号:
    10470061
  • 财政年份:
    1998
  • 资助金额:
    $ 8.77万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
Role of Monocyte Chemoattractant Protein-1 in Various Pathological Conditions
单核细胞趋化蛋白-1 在各种病理条件下的作用
  • 批准号:
    08457073
  • 财政年份:
    1996
  • 资助金额:
    $ 8.77万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了